Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chicago, IL
NPI
1194989491
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
676 N Saint Clair St Fl 7
Chicago, IL, 60611
Phone (312) 695-7970
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
2,393 services
Medicare patients, 2024
412
Average age 72
Drug cost, 2024
$3.3M
2,837 prescriptions
Company payments, 2025
$142K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wenyu Huang was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 481 times for 299 patients. In total Wenyu Huang billed 2,393 services in 35 codes, and Medicare paid $103K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 481 | 299 | $13.47 | $6,481 |
| 99214 Office E&M - Established | Office | 447 | 287 | $100.12 | $45K |
| 95251 Test - Miscellaneous | Office | 223 | 108 | $27.85 | $6,210 |
| 83036 Blood Count | Office | 156 | 111 | $9.52 | $1,485 |
| 99232 Hospital E&M - Subsequent | Facility | 109 | 42 | $67.45 | $7,352 |
| 99215 Office E&M - Established | Office | 83 | 65 | $138.16 | $11K |
| 99222 Hospital E&M - Initial | Facility | 37 | 35 | $112.62 | $4,167 |
| 96372 Injection Administration | Office | 25 | 22 | $11.15 | $279 |
| 99443 Telephone Services | Office | 24 | 24 | $92.37 | $2,217 |
| J0834 Injection, cosyntropin, 0.25 mg | Office | 21 | 18 | $19.57 | $411 |
| 36415 Venipuncture Blood Collection | Office | 21 | 19 | $8.04 | $169 |
| 95250 Test - Miscellaneous | Office | 20 | 15 | $117.54 | $2,351 |
| 99204 Office E&M - New | Office | 17 | 17 | $127.70 | $2,171 |
| 99205 Office E&M - New | Office | 14 | 14 | $177.13 | $2,480 |
| 99421 Office/Outpatient Services | Office | 12 | 11 | $8.60 | $103 |
By year: 2022 $117K for 7,413 services; 2023 $95K for 2,641 services; 2024 $103K for 2,393 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 156 | 111 | $9.52 | $1,485 |
| 36415 Venipuncture Blood Collection | 21 | 19 | $8.04 | $169 |
Medicare prescription drug claims, 2024
In 2024, the drug Wenyu Huang prescribed most often to Medicare patients was Levothyroxine Sodium, with 290 prescriptions and refills. In total Wenyu Huang wrote 2,837 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 290 | 824 | 88 | $4,170 |
| Trulicity Dulaglutide | 181 | 310 | 46 | $302K |
| Metformin Hcl Generic | 166 | 475 | 50 | $1,440 |
| Ozempic Semaglutide | 151 | 263 | 44 | $250K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 127 | 307 | 43 | $17K |
| Jardiance Empagliflozin | 120 | 337 | 43 | $192K |
| Metformin Hcl Er Metformin Hcl | 116 | 338 | 38 | $1,836 |
| Hydrocortisone Generic | 113 | 270 | 36 | $5,590 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 89 | 243 | 38 | $12K |
| Atorvastatin Calcium Generic | 66 | 198 | 26 | $523 |
| Cabergoline Generic | 63 | 152 | 22 | $11K |
| Testosterone Generic | 61 | 129 | 15 | $15K |
| Mounjaro Tirzepatide | 59 | 87 | 21 | $91K |
| Humalog Kwikpen U-100 Insulin Lispro | 55 | 137 | 23 | $16K |
| Prednisone Generic | 47 | 107 | 14 | $573 |
Brand drugs: 1,433 claims; generic drugs: 1,220 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wenyu Huang $142K ($142K in general payments such as food, travel and fees) from 9 companies. The largest payer was Neurocrine BioSciences, Inc. with $59K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.